Clinical uniformity of inflammatory bowel disease at presentation and during the first year of disease in the north and south of Europe

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients

“…Extent of disease at diagnosis in patients participating in the present study is comparable with the distribution in the original cohort, indicating that the patients in this sub-cohort were not selected in this respect. 19,44 The weakness of this study is the low number of patients included especially by some of the South European centres. This increases the risk of type 2 errors and ideally our conclusions should be confirmed in larger cohorts.…”

Clinical and economic outcomes in a population‐based European cohort of 948 ulcerative colitis and Crohn’s disease patients by Markov analysis

“…Of note, 2201 EC-IBD patients demonstrated uniformity between participating countries of the standard of diagnosis and the clinical features of disease in the first year after diagnosis. 15 The data collection process was identical in all centres in the present study. Treatment practices changed little during follow-up apart from the accelerated use of immunomodulators.…”

Risk factors for chronic thromboembolic pulmonary hypertension

“…past or healed cancer, was confirmed by surgical and pathological reports. The diagnosis of inflammatory bowel disease (IBD) was accepted if the clinical, endoscopic, histological and radiological criteria were fulfilled [12]. Evidence for prior VTE was based on clinical symptoms and documented phlebography/ultrasound evidence of deep vein thrombosis, or high probability lung scans at the time of the event.…”